DNA vaccines

Critical Reviews in Immunology

Volumn 18, Issue 5, 1998, Pages 449-484

  Lai, Wayne C ^a   Bennett, Michael ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

DNA vaccines; Expression libraries; Vector constructs

Indexed keywords

DNA VACCINE; IMMUNOGLOBULIN E; TUMOR VACCINE;

AEROSOL; ANIMAL CELL; ANTIGEN PRESENTING CELL; BACTERIAL INFECTION; CLONING VECTOR; DENDRITIC CELL; DNA LIBRARY; DRUG EFFECT; GENE EXPRESSION; HELPER CELL; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTOZOAL INFECTION; RAT; REVIEW; VACCINATION; VIRUS INFECTION;

EID: 0031710949     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: 10.1615/critrevimmunol.v18.i5.30     Document Type: Review

References (85)

1. Bolognesi, D. P., A live-virus AIDS vaccines? Not yet, it is too early to consider use of a live-attenuated virus vaccine against HlV-1, J. NIH Res., 6, 55-62, 1994.
2. Ada, G., Strategies for exploiting the immune system in design of vaccines, Mol. Immunol., 28, 225-230, 1991.
3. McKee, K. T., Jr., Brancroft, W. H., Eckels, K. H., Redfleld, R. R., and Summer, P. C., Lack of attenuation of a candidate dengue 1 vaccine (45AZ5) in human volunteers, Am. J. Trop. Med. Hyg., 36, 435-442, 1987.
4. Rabinovich, N. R., McIness, P., Klein, D. L., and Hall, B. F., Vaccine technologies: view to the future, Science, 265, 1401-1404, 1994.
5. Fynan, E. F., Webster, R. G., Fuller, D. H., Haynes, J. R., Santoro, T. C., and Robinson, H. L., DNA vaccines: Protective immunization by parenteral, mucosal and gene gun inoculation, Proc. Natl. Acad. Sci. U.S.A., 90, 11478, 1993.
6. Levine, M. M., Howe, M. M., Stocker, B. A. D., and Cadoz, M., New and improved vaccine against Typhoid fever, in New Generation Vaccine, Woodrow, G. and Levine, M. M. Eds., Marcel Dekker, New York, 1990, 269-287.
7. Sharma, S. D., Araujo, F. G., and Remington, J. S., Toxoplasma antigen isolated by affinity chromatography with monoclonal antibody protects mice against lethal infection with Toxoplasma gondii, J. Immunol., 133, 2818-2820, 1984.
8. Lai, W. C., Bennet, M., Pakes, S. P., and Murphree, S, S., Potential subunit vaccine against Mycoplasma pulmonis purified by a protective monoclonal antibody, Vaccine, 9, 177-184, 1990.
9. Crane, M. S. J., Muvry, P. K., Gnozzio, M. J., and MacDonald, T. T., Passive protection of chickens against Eimeria tenella infection by monoclonal antibody, Infect. Immunol., 56, 972-976,1983.
10. Zweerink, Hi J., Gannon, M. C., Hutchison, C. F., Jackson, J. J., Lambardo, D., Miner, K. M., Puckett, J. M., Sewell, J. J., and Sigal, N. H., Human monoclonal antibodies that protect mice against challenges with Pseudomonas aeruginosa. Infect. Immunol., 56, 1873-1879, 1988.
11. Lai, W. C., Bennett, M., Gordon, B. E., and Fakes, S. P., Protection of mice against experimental murine mycoplasmosis by a Mycoplasma pulmonis immunogen in lysogenized Escherichia coli, Vaccine, 12, 291-298, 1994.
12. Ulmer, J. B., Deck, R. R., DeWitt, C. M., Fu, T-M., Donnelly, J. J., Caulfield, M. J., and Liu, M. A., Expression of a viral protein by muscle cells in vivo induces protective cell-mediated immunity, Vaccine, 15, 839-841, 1997.
13. Albert, M. L., Sauter, B., and Bhardwaj, N., Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs, Nature, 392, 86-89, 1998.
14. Cresswell, P. and Denzin, L. K., HLA-DM induces CLIP dissociation from MHC class II α:β dimers and facilitates peptid loading, Cell, 82, 155-165, 1995.
15. Steinman, R. M., The dendritic cell system and its role in immunogenicity, Annu. Rev. Immunol., 9, 271-296, 1993.
16. Ulmer, J. B., Donnelly, J. J., Parker, S. E., Rhodes, G. H., Feigner, P. L., Dwarki, V. J., Gromkowski, S. H., Deck, R. R., Dewitt, C. M., Friedman, A., Hawe, L. A., Leander, K. R., Martinez, M., Perry, H. C., Shiver, J. W., Montgomery, D. L., and Liu, M. A., Heterologous protection against influenza by injection of DNA encoding a viral protein, Science, 259, 1745-1749, 1993.
17. Conry, R. M, Lobuglio, A. F., Kantor, J., Schlom, J., Loechel, F., Moore, S. E., Sumerel, L. A., Barlow, D. L., Abrams, S., and Curiel, D. T., Immune response to a carcinoembryonic antigen polynucleotide vaccine, Cancer Res., 54, 1164-1168, 1994.
18. Katsumi, A., Humoral and cellular immunity to an encoded protein induced by direct DNA injection, Human Gene Ther., 5, 1335-1339, 1994.
19. Zoraqui, G. and Spadafora, C., Integration of foreign DNA sequences into mouse sperm genome, DNA Cell Biol., 16, 291-300, 1997.
20. Kurth, R., Risk potential of the chromosomal insertion of foreign DNA, Ann. N.Y. Acad. Sci., 772, 140-151, 1995.
21. Tang, D., Devit, M., and Johnston, S. A., Genetic immunization is a simple method for eliciting an immune response, Nature, 356, 152-154, 1992.
22. Miller, A. D., Human gene therapy comes of age, Nature, 357, 455-460, 1992.
23. Burstyn, D. G., Baraff, L. J., Peppier, M. S., Leake, R. D., St. Gene, J., J., and manclark, C. R., Serological response to filamentous hemagglutinin and lymphocytosis-promoting toxin of Bordetella petussis; Infect. Immunol., 41, 1150-1156, 1983.
24. Whitton, J. L., Sheng, M., Oldstone, M. B., and McKee, T. A., A "string-of -beads" vaccine, comprising linked mini genes, confers protection from lethaldose virus chellenge, J. Virol., 67, 348-352, 1993.
25. Montgomery D. L., Shiver, J. W., Leander, K. R., Perry, H. C., Friedman, A., Martinez, D., Ulmer, J. B., Donnelly, J. J., and Liu, M. A., Heterologous and homologous protection against influenza A by DNA vaccination optimization of DNA vector, DNA Cell Biol., 12, 777-783, 1993.
26. Rhodes, G. H., Abai, A. M., Margalith, M., Kuwaliara-Ruhdell, A., Morrow, J., Parker, S. E., and Dwarki, V. J., Characterization of humoral immunity after DNA injection, Dev. Biol. Stand., 82, 229-236, 1994.
27. Wang, B., Ugen, K. E., Srikantan, V., Agadjanyan, M. G., Boyer, J., Williams, W. V., and Weiner, D. B., Gene inoculation generates immune responses against human immunodeficiency virus type 1, Proc. Natl. Acad. Sci. U.S.A., 90, 4156-4160, 1993.
28. Cox, G. J. M., Lamb, M. L., and Babiuk, L. A., Bovine herpesvirus 1: immune response in mice and cattle injected with plasmid DNA, J. Virol., 67, 5664-5667, 1993.
29. Xiang, Z. Q., Spitalnick, S., Tran, M., Weimer, W. H., and Chong, J., Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induce protective immunity against rabies virus, Virology, 199, 132-140, 1994.
30. Davis, H. L, Michel, M. L., and Whalen, R. G., DNA based immunization induced continuous secretion of hepatitis B surface antigen and high levels of circulating antibody, Hum. Mol. Genet., 2, 1847-1851, 1993.
31. Major, M. E., Vitvitski, L., Mink, M. A., Schleef, M., Whalen, R. G., Trepo, C., and Inchauspe, G., DNA based immunization with chimeric vectors for the induction of immune responses against the hepatitis C virus nucleo capsid, J. Virol., 69, 5798-5805, 1995.
32. Polo, J. M., Lim, B., Govindarajan, S., and Lai, M. M. C., Replication of hepatitis delta virus RNA in mice after intramuscular injection of plasmid DNA, J. Virol., 69, 5203-5207, 1995.
33. Yokoyama, M., Zhang, J., and Whitton, J. C., DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection, J. Virol., 69, 2684-2688, 1995.
34. Pedroza-Martins, L. P., Lau, L. L., Asano, M. S., and Ahmed, R., DNA vaccination against persistent viral infection, J. Virol., 69, 2574-2582, 1995.
35. Donnelly, J. J., Martinez, D., Jansen, K. U., Ellis, R. W., Montgomery, D. L., and Liu, M. A., Protection against papillomavirus with a polynucleotide vaccine, J. Infect. Dis., 713, 314-320, 1996.
36. + T lymphocytes, J. Immunol., 155, 259-265, 1995.
37. Ghiasi, H., Cai, S., Slanina, S., Newburn, A. B., and Wechsler, S. L., Vaccination of mice with Herpes simplex virus type 1 glycoprotein D DNA produces low level of protection against lethal HSV-1 challenge, Antiviral Res., 28, 147-157, 1995.
38. Lowrie D. B., Tascon, R. E., Colston, M. J., and Silva, C. L., Toward a DNA vaccine against tuberculosis, Vaccine, 12, 1537-1540, 1994.
39. Lopez-Macias, C., Lopez-Hernandez, M. A., Gonzalez, C. A., Esibasi, A., and Ortiz-Navarrete, V., Induction of antibodies against Salmonella typhii. Omx C poria by naked DNA immunization, Ann. N. Y. Acad. Sci., 772, 285-288, 1996.
40. Yang W., Waine, G. J., and McManus, P. D., Antibodies to Schistosoma japonicarum (Asian blood fluke) paramyosin by nucleic and vaccination, Biochem. Biophys. Res. Comm., 212, 1029-1039, 1995.
41. Xu, D. and Liew, F. Y., Genetic vaccination against leishmaniasis, Vaccine, 12, 1534-1536, 1994.
42. Xu, D. and Liew, F. Y., Protection against Leishmanias by injection of DNA encoding a major surface glycoprotein gp63. of L. major, Immunology, 84, 173-176, 1995.
43. Sedegah, Q., Hedstrom, R., Hobart, P., and Hoffman, S. L., Protection against malaria by humanization with circumsporozoite protein plasmid DNA, Proc. Natl. Acad. Sci. U.S.A., 91, 9866-9870, 1994.
44. Lai, W. C., Bennett, M., Barry, M., Johnson, S. A., and Pakes, S. P., Protection against Mycoplasma pulmonis infection by genetic vaccination, DNA Cell Biol., 14, 643-651, 1995.
45. Barry, M., Lai, W. C., and Johnson, S. A., Expressed library immunization is a simple method to produce a vaccine, Nature, 337, 632-635, 1995.
46. Johnston, S. A. and Barry, M., Genetic to genomic vaccination, Vaccine, 15, 808-809, 1997.
47. Lai, W. C., Pakes, S. P., Ren, K., Lu, Y. S., and Bennett, M., Therapeutic effect of DNA immunization of genetically susceptible mice infected with virulent Mycoplasma pulmonis, J. Immunol., 158, 2513-2516, 1997.
48. Conry, R. M., Lobuglio, A. F., Loechel, F., Moore, S. E., Sumerel, L. A., Barlow, D. L., and Curiel, D, T., A carcinoembryonic antigen polynucleotide vaccine has in vivo antitumor activity, Gene Ther., 2, 59-65, 1995.
49. Irvine, K. R., Rao, J. B., Rosenberg, S. A., and Restifo, N. P., Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metatases. J. Immnol., 156, 238-245, 1996.
50. Hsu, C. H., Chua, K. Y., Tao, M. H., Huang, S. K., and Hsieh, K. H., Inhibition of specific IgE response in vivo by allergen-gene transfer, Intl. Immunol., 8, 1405-1411, 1996.
51. Lee, D. J., Tighe, H., Corr, M., Roman, M., Carson, D. A., Spiegelberg, H. L., and Raz, E., Inhibition of IgE antibody formation by plasmid DNA immunization is mediated by both CD4+ and CD8+ T cells, Int. Arch. Allergy Immunol., 113, 227-230, 1987.
52. Ulmer J. B. and Liu, M. A., ELI's coming: expression library immunization and vaccine antigen discovery, Trends Microbiol., 4, 169-171, 1996.
53. Foecking, M. K. and Hofstetter, H., Powerful and versatile enhancer-promoter unit for mammalian expression vectors, Gene, 45, 101-105, 1986.
54. Chapman, B. S., Tayer, R. M., Vincent, K. A., and Haigwood, N. L., Effect of intron A from human Cytomegalovirus (Towne) immediate early gene on heterologous expression in mammalian cells, Nucl. Acid Res., 19, 3979-3986, 1991.
55. Feigner, P. L., Tsai, Y. J., Suklee, L, Wheeler, C. J., Manthorpe, M., Marshall, J., and Cheng, S. H., Improved cationic lipid formulation for in vivo gene therapy, Ann. N.Y. Acad. Sci., 712, 126-139, 1995.
56. Iwasaki, A., Niclas Stiernholm, B. J., Chan, A. K., Berinstein, N. L., and Barber, B. H., Enhanced CTL responses mediated by plasmid DNA immunogen encoding costimulatory molecules and cytokines, J. Immunol., 158, 4591-4601, 1997.
57. Kim, J. J., Bagarazzi, M. L., Trivedi, N., Hu, Y., Kazahaza, K., Wilson, D. M., Ciccarelli, R., Chattergoon, M. A., Daug, K., Mahalingam, S., Chalian, A. A., Agadjamyan, M. G., Boyer, J. D., Wang, B., and Weiner, D. B., Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes, Nat. Biotechnol., 15, 641-646, 1997.
58. Chow, Y. H., Huang, W. L., Chi, W. K., Chu, Y. D., and Tao, M. H., Improvement of heptatitis B virus DNA vaccine by plasmids coexpressing hepatitis B surface antigen and interleukin-2, J. Virol., 71, 169-178, 1997.
59. Nagel, G. J., Nabel, E. G., Yang, Z. Y., Fox, B. A., Plantz, G. E., Gao, X., Huang, L., Shu, S., Gordon, D., and Chang, A. E., Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity and lack of toxicity in humans, Proc. Natl. Acad. Sci. U.S.A., 90, 11307-11311, 1993.
60. Vahlsing, H. L., Immunization with plasmid DNA using a pneumatic gun, J. Immunol. Meth., 175, 11-22, 1994.
61. Elsenbraun, M. D., Fuller, D. H., and Haynes, J. R., Evaluation of parameters affecting the elicitation of humoral immunoresponses by peptide bombardment-mediated genetic immunization, DNA Cell Biol., 12, 791-797, 1993.
62. Yang, N. S., Luna, C. D., and Cheng, L., Gene transfer via particle bombardment: Applications of the accell gene gun, in Gene Therapeutics: Methods and Applications of Direct Gene Transfer Wolf, J. A., Ed., 1994, 193-209.
63. Johnston, S. A. and Tang, D. C., The use of microparticle injection to introduce genes Into, animal cells in vitro :and in vivo, in Genetic Engineering, Setlow, J. K., Ed., Plenum Press, New York, 1993, 225-236
64. Wolf, J. A., Ludtke, J. J., Acsadi, A., Williams, P., and Jani, A., Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle, Hum. Mol. Genet. 1, 363-369, 1992.
65. Deck, R. F., DeVitt, C. M., Donnelly, J. J., Liu, M. A., and Ulmer, J. B., Characterization of humoral immune response induced by an influenza hemagglutinen DNA vaccine, Vaccine, 15, 71-78, 1997.
66. Davis, H. C., Michel, M. C., Mancini, M., Schleef, M., and Whalen, R. G., Direct gene transfer in skeletal muscle: plasmid DNA-based immunization against the hepatitis B virus surface antigen, Vaccine, 12, 1503-1509, 1994.
67. Coney, L, Wang, B., Ugen, K. E., Boryer, J., McCallus, D., Srikantan, V., Agadjanyan, M., Paduk, C. J., Herald, K., Merva, M., Gilbert, L., Deng, K., Moelling, K., Newman, M., Williams, V. W., and Weiner, D. B., Facilitated DNA inoculation induces anti-HIV-1 immunity in vivo, Vaccine, 16, 1545-1550, 1994.
68. Zhu, N., Liggitt, D., Liu, Y., and Debo, R., Systemic gene expression after intravenous DNA delivery into adult mice, Science, 261, 209-211, 1993.
69. Whitton, J. L. and Yokoyama, M., Proteins expressed by DNA vaccines induce both local and systemic immune responses, Ann. N.Y. Acad. Sci., 797, 196-200, 1996.
70. Salmon, J. R., Armstrong, C. A., and Ansel, J. C., The skin as an immune organ, West. J. Med., 160, 146-152, 1994.
71. Raz, E., Carson, D. A., Parker, S. E., Parr, T. B., Abai, A. M., Aichinger, G., Growkowski, S. H., Singh, M., Lew, D., Yankauchas, M. E., Baird, S. M., and Rodes, G. P., Intradermal gene immunization: The possible role of DNA uptake in the induction of cellular-immunity to viruses, Proc. Natl. Acad. Sci. U.S.A., 91, 9519-9523, 1994.
72. Fynan, E. F., Webster, R. G., Fuller, D. H., Haynes, J. R., Santoro, J. C., and Robinson, H. L., DNA vaccines: a novel approach to immunization, Int. J. Immunopharmacol., 17, 79-83, 1995.
73. Shiver, J. W., Perry, H. C., Davies, M. E., and Liu, R. A., Immune responses to HIV gp120 elicited by DNA vaccination, in Vaccines 95, Brown, F., Chanock, R. M., Ginsberg, H. S., and Norrby, E., Eds., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1995, 95-98.
74. Tang, D. C., Shi, Z. K., and Curiel, D. T., Vaccination onto bare skin, Nature, 388, 729-730, 1997.
75. Ye, Y.W., Landau, C., Meidell, R. S., Willard, J. E., Moskowitz, A., Aziz, S., Carlisle, E., Nelson, K., and Eberhart, R. C., Improved bioresobable microporous intravascular stents for gene therapy, ASAIO J., 42, M823-M827, 1996.
76. Sizemore, D. R., Branstrom, A. A., and Sadoff, J. C., Attenuated Schigella as a DNA delivery vehicle for DNA-mediated immunization, Science, 270, 299-302, 1995.
77. Sansonetti, P. J., HaIe, Dammin, G. J., Kapfer, C., Collins, H. H., Jr.,and Formal, S. B., Alternation in the pathogenicity of Escherichia coli K-12 after transfer of plasimid and chromosomal genes from Schigella flexneri, Infect, Immun., 39, 1392-1402, 1983.
78. Portnoy, D. A. and Jones, S., The cell biology of Listeria monocytogenes infection, Ann. N.Y. Acad. Sci., 730, 15-25, 1994.
79. Gerloni, M., Billetta, R., Xiong, S., and Zanetti, M., Somatic transgene immunization with DNA encoding animmunoglobulin heavy chain, Vaccine, 16, 611-625, 1997.
80. Wang, B., Boyer, J., Srikautan, V., Coney, L., Carrano, R., Phan, C., Merva, M., Dang, K., Agadjanyan, M., Gilbert, L., Ugen, K. E., Ugen, K. E.,Williams, W. V., and Weiner, D. B., DNA inoculation induces neutralizing immune responses against human immunodeficiency Virus type 1 in mice and nonhuman primates, DNA Cell Biol., 12, 799-805, 1993.
81. Lagging, L. M., Meyer, K., Hoft, D., Houghton, M., Belshe, R. B., and Ray, R., Immune responses to plasmid DNA encoding the hepatitis C virus core protein, J. Virol., 69, 5859-5863, 1995.
82. Hoofnagle, J. H., Type D (delta) hepatitis, JAMA. 261, 1321-1325, 1989.
83. Yokoyama, M., Zhang, J., and Whitton, J. L., DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection, J. Virol., 69, 2684-2688, 1995.
84. Lin, Y. L., Borenstein, L. A., Ahmed, R., and Wettstein, F. O., Cottontail rabbit Papillomavirus L1 protein-based vaccines: Protection is achieved only with a full-length nondenatured product, J. Virol., 678, 4154-4162, 1993.
85. Kriesel, J. D., Spniance, S. L., Daynes, R. A., and Araneo, B. A., Nucleic acid vaccine encoding D1 protects mice from Herpes simplex virus type 2 disease, J. Infect. Dis., 173, 536-541, 1996.